文献速递冠心病

血管内超声指导药物洗脱支架置入在急性冠脉综合征患者中的长期结局:ULTIMATE ACS亚组分析

[Long-term outcomes of intravascular ultrasound-guided drug-eluting stents implantation in patients with acute coronary syndrome: ULTIMATE ACS subgroup].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2024-01-01

结果显示ACS组3年靶血管失败率(9.6%)显著高于非ACS组(4.5%),而IVUS指导可显著降低ACS患者3年TVF风险,且IVUS达标者获益更明显。

要点

  • ACS患者置入DES后3年靶血管失败率显著高于非ACS患者(9.6% vs 4.5%)。
  • IVUS指导较冠脉造影显著降低ACS患者3年TVF风险(7.6% vs 11.6%)。
  • IVUS指导下置入达标者3年TVF率进一步降低至5.4%,低于未达标组的9.9%。

核心结论

  • ACS患者置入DES后3年TVF事件率高于无ACS患者,IVUS指导可显著降低ACS患者3年TVF事件,尤其IVUS达标者获益更明显。

研究设计与样本

  • 将患者分为ACS组和非ACS组,两组均在IVUS或冠状动脉造影指导下置入DES。
  • 主要终点为术后3年靶血管失败(TVF),包含心原性死亡、靶血管心肌梗死和临床驱动的靶血管血运重建。

主要发现

  • ACS组中IVUS指导组TVF发生率为7.6%(43/569),低于冠状动脉造影指导组的11.6%(66/567),log-rank P=0.019。
  • ACS组中IVUS指导下DES置入达标组3年TVF发生率为5.4%(16/296),低于IVUS未达标组的9.9%(27/273),log-rank P=0.041。

临床怎么用

  • 对于ACS患者置入DES,IVUS指导可降低3年TVF风险,应考虑优先使用IVUS指导。
  • IVUS指导下置入达标(如支架膨胀、贴壁良好等)可使ACS患者获益更明显,应追求IVUS达标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the long-term effects of intravascular ultrasound (IVUS) guidance on patients with acute coronary syndrome (ACS) undergoing drug-eluting stents (DES) implantation. Methods: Data used in this study derived from ULTIMATE trial, which was a prospective, multicenter, randomized study. A total of 1 448 all-comer patients were enrolled between 2014 August and 2017 May. Primary endpoint of this study was target vessel failure (TVF) at 3 years, including cardiac death, target-vessel-related myocardial infarction, and clinically-driven target vessel revascularization. Results: ACS was present in 1 136 (78.5%) patients, and 3-year clinical follow-up was available in 1 423 patients (98.3%). TVF in the ACS group was 9.6% (109/1 136), which was significantly higher than 4.5% (14/312) in the non-ACS group (log-rank P=0.005). There were 109 TVFs in the ACS patients, with 7.6% (43/569) TVFs in the IVUS group and 11.6% (66/567) TVFs in the angiography group (log-rank P=0.019). Moreover, patients with optimal IVUS guidance were associated with a lower risk of 3-year TVF compared to those with suboptimal IVUS results (5.4% (16/296) vs. 9.9% (27/273),log-rank P=0.041). Conclusions: This ULTIMATE-ACS subgroup analysis showed that ACS patients undergoing DES implantation were associated with a higher risk of 3-year TVF. More importantly, the risk of TVF could be significantly decreased through IVUS guidance in patients with ACS, especially in those who had an IVUS-defined optimal procedure. 目的: 评估血管内超声(IVUS)指导药物洗脱支架(DES)置入对急性冠脉综合征(ACS)患者长期临床结局的影响。 方法: 研究对象来源于ULTIMATE研究,该研究是一项前瞻性、多中心、随机对照研究,于2014年8月—2017年5月在国内8家医院入选1 448例置入DES的冠心病患者。本研究为ULTIMATE研究的亚组分析,将冠心病患者分为ACS组和非ACS组,2组患者均在IVUS或冠状动脉造影指导下置入DES。主要终点是术后3年靶血管失败(TVF)率,包含心原性死亡、靶血管心肌梗死和临床驱动的靶血管血运重建。 结果: 1 448例冠心病患者中,ACS组1 136例(78.5%),1 423例(98.3%)患者完成术后3年随访。ACS组患者术后3年的TVF发生率为9.6%(109/1 136),高于非ACS组的4.5%(14/312),log-rank P=0.005。ACS组中IVUS指导下置入DES者的TVF发生率低于冠状动脉造影指导下置入DES架者[7.6%(43/569)比11.6%(66/567),log-rank P=0.019]。ACS组中IVUS指导下DES置入达标组患者术后3年的TVF发生率为5.4%(16/296),低于IVUS未达标组的9.9%(27/273),log-rank P=0.041。 结论: ACS患者置入DES后3年的TVF事件率高于无ACS患者;相比于冠状动脉造影,IVUS指导DES置入可以降低ACS患者术后3年的TVF事件,尤其是IVUS指导下DES置入达标的患者获益更明显。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Gao, Han, Qian, et al. [Long-term outcomes of intravascular ultrasound-guided drug-eluting stents implantation in patients with acute coronary syndrome: ULTIMATE ACS subgroup]. Zhonghua Xin Xue Guan Bing Za Zhi. 2024. PMID: 38326064. doi:10.3760/cma.j.cn112148-20231008-00239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。